Key Insights
The European In Vitro Diagnostics (IVD) market is poised for significant expansion, with an estimated market size of USD 21.19 billion in 2025, driven by a robust compound annual growth rate (CAGR) of 7.9% throughout the forecast period. This dynamic growth is fueled by an increasing prevalence of chronic and infectious diseases, a growing demand for personalized medicine, and advancements in diagnostic technologies. Key drivers include rising healthcare expenditures, an aging population susceptible to various health conditions, and a proactive approach to early disease detection and management across European nations. The market's expansion is further bolstered by technological innovations, such as the development of point-of-care testing (POCT) devices and the integration of artificial intelligence and machine learning in diagnostic platforms, enhancing accuracy and efficiency.
European In Vitro Diagnostics Market Market Size (In Billion)
The IVD market in Europe is characterized by diverse segments, with Clinical Chemistry and Molecular Diagnostics leading in terms of test types, reflecting the growing importance of genetic testing and pathogen identification. Reagents constitute a substantial product segment, alongside instruments, catering to the ongoing need for consumable diagnostic materials. The increasing adoption of disposable IVD devices is a notable trend, driven by convenience and infection control measures. Geographically, while specific regional data is not provided, it is logical to infer that major economies like Germany, France, and the United Kingdom, with their well-established healthcare infrastructures and significant R&D investments, are key contributors to the European IVD market share. Restraints may include stringent regulatory hurdles and the high cost of advanced diagnostic technologies, though innovation and market competition are expected to mitigate these challenges over the study period.
European In Vitro Diagnostics Market Company Market Share
Unlock critical insights into the dynamic European in vitro diagnostics (IVD) market. This comprehensive report details market size, growth drivers, competitive landscape, and future projections for the European IVD sector from 2019 to 2033. Delve into parent and child market analyses, segment-specific trends, and the impact of key industry developments and leading players. With data segmented by test type, product, usability, application, and end-user, this report provides an unparalleled understanding of the market's evolution and strategic opportunities. Forecasts are based on a 2025 base and estimated year, with detailed analysis for the 2025-2033 period and historical data from 2019-2024.
European In Vitro Diagnostics Market Market Dynamics & Structure
The European in vitro diagnostics (IVD) market is characterized by a moderately concentrated competitive landscape, driven by significant technological innovation and a stringent yet supportive regulatory framework, particularly the IVDR. Key drivers include advancements in molecular diagnostics, rising demand for early disease detection across applications like infectious diseases and cancer/oncology, and the increasing adoption of automated diagnostic laboratories and advanced hospitals and clinics. Competitive product substitutes are emerging from point-of-care testing (POCT) solutions and novel assay development. End-user demographics are shifting towards an aging population with a higher prevalence of chronic diseases, fueling demand for advanced diagnostic solutions. Mergers & Acquisitions (M&A) activity remains robust, with companies seeking to expand their product portfolios and geographic reach.
- Market Concentration: Dominated by a few large players, but with a growing number of specialized SMEs.
- Technological Innovation Drivers: Miniaturization, AI in diagnostics, liquid biopsy, multiplex assays.
- Regulatory Frameworks: Impact of IVDR on product approval and market entry.
- Competitive Product Substitutes: POCT, lab-on-a-chip technologies.
- End-User Demographics: Aging population, increasing chronic disease burden.
- M&A Trends: Strategic acquisitions for technology integration and market expansion.
European In Vitro Diagnostics Market Growth Trends & Insights
The European in vitro diagnostics market is poised for substantial growth, with an estimated market size of $XX billion in 2025, projected to reach $XX billion by 2033, exhibiting a Compound Annual Growth Rate (CAGR) of XX% during the forecast period. This expansion is fueled by increasing healthcare expenditure, a growing emphasis on preventive medicine, and the continuous development of innovative diagnostic technologies. The adoption rates for advanced IVD solutions, particularly in molecular diagnostics and immuno diagnostics, are steadily rising due to their enhanced sensitivity and specificity in disease detection and management. Technological disruptions, such as the integration of artificial intelligence (AI) and machine learning (ML) into diagnostic platforms, are revolutionizing data analysis and interpretation, leading to more accurate and timely diagnoses. Shifts in consumer behavior, including a greater awareness of personal health and proactive engagement with healthcare providers, are further accelerating the demand for accessible and efficient diagnostic testing. The disposable IVD devices segment is experiencing particularly strong growth, driven by the convenience and reduced risk of cross-contamination offered by these products. The increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases, coupled with a heightened focus on early cancer detection through cancer/oncology diagnostics, are significant market accelerators. Furthermore, the expanding capabilities of diagnostic laboratories to offer a wider range of sophisticated tests and the increasing demand for personalized medicine approaches are contributing to the market's upward trajectory. The integration of digital health solutions and telehealth platforms is also playing a crucial role in expanding access to IVD services, especially in remote or underserved areas across Europe. The market is also witnessing a surge in demand for rapid and accurate testing for infectious diseases, a trend amplified by recent global health events.
Dominant Regions, Countries, or Segments in European In Vitro Diagnostics Market
The Molecular Diagnostics segment, within the Test Type category, is a significant growth engine for the European IVD market, projected to reach $XX billion in 2025. This dominance is driven by its unparalleled ability to detect genetic mutations, infectious agents, and biomarkers with high precision, crucial for personalized medicine, oncology, and infectious disease management. Within the Product segment, Reagents are expected to command the largest market share, estimated at $XX billion in 2025, due to their consumable nature and the continuous need for them in all diagnostic procedures. In terms of Usability, Disposable IVD Devices are anticipated to show robust growth, driven by convenience, infection control, and the increasing adoption of point-of-care testing. For Applications, Infectious Disease diagnostics remain a pivotal segment, further boosted by the ongoing need for rapid and accurate pathogen identification, projected to be valued at $XX billion in 2025. The Diagnostic Laboratories end-user segment will continue to be the largest, driven by their central role in performing a vast array of diagnostic tests and their investment in advanced instrumentation and technologies.
Leading Segments:
- Test Type: Molecular Diagnostics (Market Share: XX%, Value: $XX billion in 2025)
- Product: Reagents (Market Share: XX%, Value: $XX billion in 2025)
- Usability: Disposable IVD Devices (Growth Rate: XX% CAGR)
- Application: Infectious Disease (Value: $XX billion in 2025)
- End User: Diagnostic Laboratories (Market Share: XX%, Value: $XX billion in 2025)
Dominance Factors:
- Molecular Diagnostics: Precision, personalized medicine applications, rising cancer incidence.
- Reagents: High consumption rates, necessity for various tests, continuous innovation in assay development.
- Disposable IVD Devices: Infection control benefits, ease of use, point-of-care adoption.
- Infectious Disease: Public health preparedness, emerging pathogens, routine screening.
- Diagnostic Laboratories: Centralized testing infrastructure, investment capacity, demand for comprehensive services.
European In Vitro Diagnostics Market Product Landscape
The European IVD market's product landscape is characterized by continuous innovation aimed at enhancing diagnostic accuracy, speed, and accessibility. Key developments include the introduction of highly sensitive molecular diagnostics platforms capable of multiplex testing, enabling the simultaneous detection of multiple analytes from a single sample. Advancements in immuno diagnostics are leading to the development of novel assays with improved detection limits for early disease identification. The market also sees a proliferation of automated instrument systems that streamline laboratory workflows and reduce turnaround times. Furthermore, the development of user-friendly reagents and kits designed for both laboratory and point-of-care settings is expanding the reach of IVD testing. The focus on disposable IVD devices underscores a commitment to patient safety and operational efficiency.
Key Drivers, Barriers & Challenges in European In Vitro Diagnostics Market
Key Drivers:
- Technological Advancements: Continuous innovation in areas like genomics, proteomics, and AI is creating novel diagnostic capabilities.
- Rising Prevalence of Chronic Diseases: Growing incidence of conditions like diabetes, cancer, and autoimmune disorders drives demand for early and accurate diagnostics.
- Government Initiatives & Healthcare Spending: Increased public and private investment in healthcare infrastructure and R&D fuels market growth.
- Aging Population: The demographic shift towards an older population increases the demand for diagnostic tests associated with age-related illnesses.
Barriers & Challenges:
- Stringent Regulatory Landscape: Navigating complex and evolving regulations, particularly the IVDR, can be time-consuming and costly for manufacturers.
- Reimbursement Policies: Inconsistent or unfavorable reimbursement policies across European countries can impact market adoption.
- High Cost of Advanced Technologies: The significant investment required for sophisticated IVD instruments and reagents can be a barrier for smaller healthcare providers.
- Skilled Workforce Shortage: A lack of trained professionals to operate and interpret results from advanced diagnostic equipment poses a challenge.
- Supply Chain Disruptions: Global events can impact the availability and cost of raw materials and finished products.
Emerging Opportunities in European In Vitro Diagnostics Market
Emerging opportunities in the European IVD market lie in the expansion of point-of-care testing (POCT) solutions, particularly for infectious diseases and chronic condition management, offering faster results closer to the patient. The growing demand for personalized medicine is opening avenues for companion diagnostics and genetic testing. The integration of digital health and AI into IVD platforms presents opportunities for predictive diagnostics and enhanced data analytics. Furthermore, the untapped potential in emerging European economies and the increasing focus on early detection of rare diseases represent significant growth avenues for innovative IVD players.
Growth Accelerators in the European In Vitro Diagnostics Market Industry
Growth in the European IVD industry is being significantly accelerated by strategic partnerships and collaborations between IVD manufacturers and research institutions, fostering the development of next-generation diagnostic tools. The increasing adoption of automation and AI in diagnostic workflows is enhancing efficiency and accuracy, driving down costs and improving throughput. Furthermore, market expansion strategies by key players, focusing on underserved regions and specific disease areas, are contributing to the overall growth momentum. The ongoing shift towards preventive healthcare and early disease detection further bolsters the long-term growth prospects of the industry.
Key Players Shaping the European In Vitro Diagnostics Market Market
- Becton Dickinson and Company
- BioMerieux SA
- Tesa SE
- Bio-Rad Laboratories Inc
- Illumina Inc
- Siemens Healthcare
- Hologic Inc
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- Diasorin S p A
- Danaher Corporation (Beckman Coulter Inc)
- Sysmex Corporation
- QIAGEN
- Roche Diagnostics
Notable Milestones in European In Vitro Diagnostics Market Sector
- March 2023: MGI Tech Co., Ltd. received the CE mark for the DNBSeq-G99 sequencer, enhancing precise genetic substance sequencing capabilities.
- December 2022: BioMérieux SA obtained the CE mark for its Vidas Kube automated immunoassay system, expanding diagnostic capabilities for immunochemistry, infectious diseases, and food industry pathogens.
- September 2022: Noul Co., Ltd. secured the CE-IVD mark for its miLab Cartridge CER and miLab Cartridge BCM, strengthening its product line in in-vitro diagnostics systems.
In-Depth European In Vitro Diagnostics Market Market Outlook
The future outlook for the European in vitro diagnostics market is exceptionally positive, driven by a confluence of technological breakthroughs and evolving healthcare needs. The increasing integration of AI and machine learning in diagnostic platforms promises to unlock predictive and personalized healthcare paradigms, significantly enhancing early disease detection and treatment efficacy. Strategic partnerships and collaborations will continue to be pivotal in accelerating R&D and market penetration, particularly in niche therapeutic areas and for novel diagnostic applications. Furthermore, the ongoing expansion of molecular diagnostics and next-generation sequencing technologies will fuel personalized medicine initiatives across oncology, rare diseases, and infectious disease management. As European healthcare systems increasingly prioritize preventive care and efficient patient management, the demand for advanced, accessible, and cost-effective IVD solutions will continue to surge, positioning the market for sustained and robust growth.
European In Vitro Diagnostics Market Segmentation
-
1. Test Type
- 1.1. Clinical Chemistry
- 1.2. Molecular Diagnostics
- 1.3. Hematology
- 1.4. Immuno Diagnostics
- 1.5. Other Test Types
-
2. Product
- 2.1. Instrument
- 2.2. Reagents
- 2.3. Other Products
-
3. Usability
- 3.1. Disposable IVD Devices
- 3.2. Reusable IVD Devices
-
4. Application
- 4.1. Infectious Disease
- 4.2. Diabetes
- 4.3. Cancer/Oncology
- 4.4. Cardiology
- 4.5. Autoimmune Disease
- 4.6. Nephrology
- 4.7. Other Applications
-
5. End User
- 5.1. Diagnostic Laboratories
- 5.2. Hospitals and Clinics
- 5.3. Other End Users
European In Vitro Diagnostics Market Segmentation By Geography
- 1. Germany
- 2. United Kingdom
- 3. France
- 4. Italy
- 5. Spain
- 6. Rest of Europe
European In Vitro Diagnostics Market Regional Market Share
Geographic Coverage of European In Vitro Diagnostics Market
European In Vitro Diagnostics Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 7.9% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. High Prevalence of Chronic Diseases; Increasing Demand for Point-of-care Diagnostics; Technological Advancements in In-Vitro Diagnostics Devices
- 3.3. Market Restrains
- 3.3.1. Stringent Regulations; Cumbersome Reimbursement Procedures
- 3.4. Market Trends
- 3.4.1. The Instrument Segment is Expected to Hold a Major Share in the Market
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Test Type
- 5.1.1. Clinical Chemistry
- 5.1.2. Molecular Diagnostics
- 5.1.3. Hematology
- 5.1.4. Immuno Diagnostics
- 5.1.5. Other Test Types
- 5.2. Market Analysis, Insights and Forecast - by Product
- 5.2.1. Instrument
- 5.2.2. Reagents
- 5.2.3. Other Products
- 5.3. Market Analysis, Insights and Forecast - by Usability
- 5.3.1. Disposable IVD Devices
- 5.3.2. Reusable IVD Devices
- 5.4. Market Analysis, Insights and Forecast - by Application
- 5.4.1. Infectious Disease
- 5.4.2. Diabetes
- 5.4.3. Cancer/Oncology
- 5.4.4. Cardiology
- 5.4.5. Autoimmune Disease
- 5.4.6. Nephrology
- 5.4.7. Other Applications
- 5.5. Market Analysis, Insights and Forecast - by End User
- 5.5.1. Diagnostic Laboratories
- 5.5.2. Hospitals and Clinics
- 5.5.3. Other End Users
- 5.6. Market Analysis, Insights and Forecast - by Region
- 5.6.1. Germany
- 5.6.2. United Kingdom
- 5.6.3. France
- 5.6.4. Italy
- 5.6.5. Spain
- 5.6.6. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Test Type
- 6. Germany European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Test Type
- 6.1.1. Clinical Chemistry
- 6.1.2. Molecular Diagnostics
- 6.1.3. Hematology
- 6.1.4. Immuno Diagnostics
- 6.1.5. Other Test Types
- 6.2. Market Analysis, Insights and Forecast - by Product
- 6.2.1. Instrument
- 6.2.2. Reagents
- 6.2.3. Other Products
- 6.3. Market Analysis, Insights and Forecast - by Usability
- 6.3.1. Disposable IVD Devices
- 6.3.2. Reusable IVD Devices
- 6.4. Market Analysis, Insights and Forecast - by Application
- 6.4.1. Infectious Disease
- 6.4.2. Diabetes
- 6.4.3. Cancer/Oncology
- 6.4.4. Cardiology
- 6.4.5. Autoimmune Disease
- 6.4.6. Nephrology
- 6.4.7. Other Applications
- 6.5. Market Analysis, Insights and Forecast - by End User
- 6.5.1. Diagnostic Laboratories
- 6.5.2. Hospitals and Clinics
- 6.5.3. Other End Users
- 6.1. Market Analysis, Insights and Forecast - by Test Type
- 7. United Kingdom European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Test Type
- 7.1.1. Clinical Chemistry
- 7.1.2. Molecular Diagnostics
- 7.1.3. Hematology
- 7.1.4. Immuno Diagnostics
- 7.1.5. Other Test Types
- 7.2. Market Analysis, Insights and Forecast - by Product
- 7.2.1. Instrument
- 7.2.2. Reagents
- 7.2.3. Other Products
- 7.3. Market Analysis, Insights and Forecast - by Usability
- 7.3.1. Disposable IVD Devices
- 7.3.2. Reusable IVD Devices
- 7.4. Market Analysis, Insights and Forecast - by Application
- 7.4.1. Infectious Disease
- 7.4.2. Diabetes
- 7.4.3. Cancer/Oncology
- 7.4.4. Cardiology
- 7.4.5. Autoimmune Disease
- 7.4.6. Nephrology
- 7.4.7. Other Applications
- 7.5. Market Analysis, Insights and Forecast - by End User
- 7.5.1. Diagnostic Laboratories
- 7.5.2. Hospitals and Clinics
- 7.5.3. Other End Users
- 7.1. Market Analysis, Insights and Forecast - by Test Type
- 8. France European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Test Type
- 8.1.1. Clinical Chemistry
- 8.1.2. Molecular Diagnostics
- 8.1.3. Hematology
- 8.1.4. Immuno Diagnostics
- 8.1.5. Other Test Types
- 8.2. Market Analysis, Insights and Forecast - by Product
- 8.2.1. Instrument
- 8.2.2. Reagents
- 8.2.3. Other Products
- 8.3. Market Analysis, Insights and Forecast - by Usability
- 8.3.1. Disposable IVD Devices
- 8.3.2. Reusable IVD Devices
- 8.4. Market Analysis, Insights and Forecast - by Application
- 8.4.1. Infectious Disease
- 8.4.2. Diabetes
- 8.4.3. Cancer/Oncology
- 8.4.4. Cardiology
- 8.4.5. Autoimmune Disease
- 8.4.6. Nephrology
- 8.4.7. Other Applications
- 8.5. Market Analysis, Insights and Forecast - by End User
- 8.5.1. Diagnostic Laboratories
- 8.5.2. Hospitals and Clinics
- 8.5.3. Other End Users
- 8.1. Market Analysis, Insights and Forecast - by Test Type
- 9. Italy European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Test Type
- 9.1.1. Clinical Chemistry
- 9.1.2. Molecular Diagnostics
- 9.1.3. Hematology
- 9.1.4. Immuno Diagnostics
- 9.1.5. Other Test Types
- 9.2. Market Analysis, Insights and Forecast - by Product
- 9.2.1. Instrument
- 9.2.2. Reagents
- 9.2.3. Other Products
- 9.3. Market Analysis, Insights and Forecast - by Usability
- 9.3.1. Disposable IVD Devices
- 9.3.2. Reusable IVD Devices
- 9.4. Market Analysis, Insights and Forecast - by Application
- 9.4.1. Infectious Disease
- 9.4.2. Diabetes
- 9.4.3. Cancer/Oncology
- 9.4.4. Cardiology
- 9.4.5. Autoimmune Disease
- 9.4.6. Nephrology
- 9.4.7. Other Applications
- 9.5. Market Analysis, Insights and Forecast - by End User
- 9.5.1. Diagnostic Laboratories
- 9.5.2. Hospitals and Clinics
- 9.5.3. Other End Users
- 9.1. Market Analysis, Insights and Forecast - by Test Type
- 10. Spain European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Test Type
- 10.1.1. Clinical Chemistry
- 10.1.2. Molecular Diagnostics
- 10.1.3. Hematology
- 10.1.4. Immuno Diagnostics
- 10.1.5. Other Test Types
- 10.2. Market Analysis, Insights and Forecast - by Product
- 10.2.1. Instrument
- 10.2.2. Reagents
- 10.2.3. Other Products
- 10.3. Market Analysis, Insights and Forecast - by Usability
- 10.3.1. Disposable IVD Devices
- 10.3.2. Reusable IVD Devices
- 10.4. Market Analysis, Insights and Forecast - by Application
- 10.4.1. Infectious Disease
- 10.4.2. Diabetes
- 10.4.3. Cancer/Oncology
- 10.4.4. Cardiology
- 10.4.5. Autoimmune Disease
- 10.4.6. Nephrology
- 10.4.7. Other Applications
- 10.5. Market Analysis, Insights and Forecast - by End User
- 10.5.1. Diagnostic Laboratories
- 10.5.2. Hospitals and Clinics
- 10.5.3. Other End Users
- 10.1. Market Analysis, Insights and Forecast - by Test Type
- 11. Rest of Europe European In Vitro Diagnostics Market Analysis, Insights and Forecast, 2020-2032
- 11.1. Market Analysis, Insights and Forecast - by Test Type
- 11.1.1. Clinical Chemistry
- 11.1.2. Molecular Diagnostics
- 11.1.3. Hematology
- 11.1.4. Immuno Diagnostics
- 11.1.5. Other Test Types
- 11.2. Market Analysis, Insights and Forecast - by Product
- 11.2.1. Instrument
- 11.2.2. Reagents
- 11.2.3. Other Products
- 11.3. Market Analysis, Insights and Forecast - by Usability
- 11.3.1. Disposable IVD Devices
- 11.3.2. Reusable IVD Devices
- 11.4. Market Analysis, Insights and Forecast - by Application
- 11.4.1. Infectious Disease
- 11.4.2. Diabetes
- 11.4.3. Cancer/Oncology
- 11.4.4. Cardiology
- 11.4.5. Autoimmune Disease
- 11.4.6. Nephrology
- 11.4.7. Other Applications
- 11.5. Market Analysis, Insights and Forecast - by End User
- 11.5.1. Diagnostic Laboratories
- 11.5.2. Hospitals and Clinics
- 11.5.3. Other End Users
- 11.1. Market Analysis, Insights and Forecast - by Test Type
- 12. Competitive Analysis
- 12.1. Market Share Analysis 2025
- 12.2. Company Profiles
- 12.2.1 Becton Dickinson and Company
- 12.2.1.1. Overview
- 12.2.1.2. Products
- 12.2.1.3. SWOT Analysis
- 12.2.1.4. Recent Developments
- 12.2.1.5. Financials (Based on Availability)
- 12.2.2 BioMerieux SA
- 12.2.2.1. Overview
- 12.2.2.2. Products
- 12.2.2.3. SWOT Analysis
- 12.2.2.4. Recent Developments
- 12.2.2.5. Financials (Based on Availability)
- 12.2.3 Tesa SE
- 12.2.3.1. Overview
- 12.2.3.2. Products
- 12.2.3.3. SWOT Analysis
- 12.2.3.4. Recent Developments
- 12.2.3.5. Financials (Based on Availability)
- 12.2.4 Bio-Rad Laboratories Inc
- 12.2.4.1. Overview
- 12.2.4.2. Products
- 12.2.4.3. SWOT Analysis
- 12.2.4.4. Recent Developments
- 12.2.4.5. Financials (Based on Availability)
- 12.2.5 Illumina Inc
- 12.2.5.1. Overview
- 12.2.5.2. Products
- 12.2.5.3. SWOT Analysis
- 12.2.5.4. Recent Developments
- 12.2.5.5. Financials (Based on Availability)
- 12.2.6 Siemens Healthcare
- 12.2.6.1. Overview
- 12.2.6.2. Products
- 12.2.6.3. SWOT Analysis
- 12.2.6.4. Recent Developments
- 12.2.6.5. Financials (Based on Availability)
- 12.2.7 Hologic Inc
- 12.2.7.1. Overview
- 12.2.7.2. Products
- 12.2.7.3. SWOT Analysis
- 12.2.7.4. Recent Developments
- 12.2.7.5. Financials (Based on Availability)
- 12.2.8 Thermo Fisher Scientific Inc
- 12.2.8.1. Overview
- 12.2.8.2. Products
- 12.2.8.3. SWOT Analysis
- 12.2.8.4. Recent Developments
- 12.2.8.5. Financials (Based on Availability)
- 12.2.9 Abbott Laboratories
- 12.2.9.1. Overview
- 12.2.9.2. Products
- 12.2.9.3. SWOT Analysis
- 12.2.9.4. Recent Developments
- 12.2.9.5. Financials (Based on Availability)
- 12.2.10 Diasorin S p A
- 12.2.10.1. Overview
- 12.2.10.2. Products
- 12.2.10.3. SWOT Analysis
- 12.2.10.4. Recent Developments
- 12.2.10.5. Financials (Based on Availability)
- 12.2.11 Danaher Corporation (Beckman Coulter Inc)
- 12.2.11.1. Overview
- 12.2.11.2. Products
- 12.2.11.3. SWOT Analysis
- 12.2.11.4. Recent Developments
- 12.2.11.5. Financials (Based on Availability)
- 12.2.12 Sysmex Corporation
- 12.2.12.1. Overview
- 12.2.12.2. Products
- 12.2.12.3. SWOT Analysis
- 12.2.12.4. Recent Developments
- 12.2.12.5. Financials (Based on Availability)
- 12.2.13 QIAGEN
- 12.2.13.1. Overview
- 12.2.13.2. Products
- 12.2.13.3. SWOT Analysis
- 12.2.13.4. Recent Developments
- 12.2.13.5. Financials (Based on Availability)
- 12.2.14 Roche Diagnostics
- 12.2.14.1. Overview
- 12.2.14.2. Products
- 12.2.14.3. SWOT Analysis
- 12.2.14.4. Recent Developments
- 12.2.14.5. Financials (Based on Availability)
- 12.2.1 Becton Dickinson and Company
List of Figures
- Figure 1: European In Vitro Diagnostics Market Revenue Breakdown (billion, %) by Product 2025 & 2033
- Figure 2: European In Vitro Diagnostics Market Share (%) by Company 2025
List of Tables
- Table 1: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 2: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 3: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 4: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 5: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 6: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 7: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 8: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 9: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 10: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 11: European In Vitro Diagnostics Market Revenue billion Forecast, by Region 2020 & 2033
- Table 12: European In Vitro Diagnostics Market Volume K Unit Forecast, by Region 2020 & 2033
- Table 13: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 14: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 15: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 16: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 17: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 18: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 19: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 20: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 21: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 22: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 23: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 24: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 25: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 26: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 27: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 28: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 29: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 30: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 31: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 32: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 33: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 34: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 35: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 36: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 37: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 38: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 39: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 40: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 41: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 42: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 43: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 44: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 45: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 46: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 47: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 48: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 49: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 50: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 51: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 52: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 53: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 54: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 55: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 56: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 57: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 58: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 59: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 60: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 61: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 62: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 63: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 64: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 65: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 66: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 67: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 68: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 69: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 70: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 71: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 72: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
- Table 73: European In Vitro Diagnostics Market Revenue billion Forecast, by Test Type 2020 & 2033
- Table 74: European In Vitro Diagnostics Market Volume K Unit Forecast, by Test Type 2020 & 2033
- Table 75: European In Vitro Diagnostics Market Revenue billion Forecast, by Product 2020 & 2033
- Table 76: European In Vitro Diagnostics Market Volume K Unit Forecast, by Product 2020 & 2033
- Table 77: European In Vitro Diagnostics Market Revenue billion Forecast, by Usability 2020 & 2033
- Table 78: European In Vitro Diagnostics Market Volume K Unit Forecast, by Usability 2020 & 2033
- Table 79: European In Vitro Diagnostics Market Revenue billion Forecast, by Application 2020 & 2033
- Table 80: European In Vitro Diagnostics Market Volume K Unit Forecast, by Application 2020 & 2033
- Table 81: European In Vitro Diagnostics Market Revenue billion Forecast, by End User 2020 & 2033
- Table 82: European In Vitro Diagnostics Market Volume K Unit Forecast, by End User 2020 & 2033
- Table 83: European In Vitro Diagnostics Market Revenue billion Forecast, by Country 2020 & 2033
- Table 84: European In Vitro Diagnostics Market Volume K Unit Forecast, by Country 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the European In Vitro Diagnostics Market?
The projected CAGR is approximately 7.9%.
2. Which companies are prominent players in the European In Vitro Diagnostics Market?
Key companies in the market include Becton Dickinson and Company, BioMerieux SA, Tesa SE, Bio-Rad Laboratories Inc, Illumina Inc , Siemens Healthcare, Hologic Inc, Thermo Fisher Scientific Inc, Abbott Laboratories, Diasorin S p A, Danaher Corporation (Beckman Coulter Inc), Sysmex Corporation, QIAGEN, Roche Diagnostics.
3. What are the main segments of the European In Vitro Diagnostics Market?
The market segments include Test Type, Product, Usability, Application, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 21.19 billion as of 2022.
5. What are some drivers contributing to market growth?
High Prevalence of Chronic Diseases; Increasing Demand for Point-of-care Diagnostics; Technological Advancements in In-Vitro Diagnostics Devices.
6. What are the notable trends driving market growth?
The Instrument Segment is Expected to Hold a Major Share in the Market.
7. Are there any restraints impacting market growth?
Stringent Regulations; Cumbersome Reimbursement Procedures.
8. Can you provide examples of recent developments in the market?
In March 2023, MGI Tech Co., Ltd. received the CE mark for the DNBSeq-G99 sequencer with an aim to precise sequencing of genetic substances.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in billion and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "European In Vitro Diagnostics Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the European In Vitro Diagnostics Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the European In Vitro Diagnostics Market?
To stay informed about further developments, trends, and reports in the European In Vitro Diagnostics Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence